Background
==========

Preeclampsia is one of the major health problems during pregnancy. It complicates 3%--8% of pregnancies and causes marked increase in perinatal, maternal morbidity, and mortality.[@b1-vhrm-12-477]--[@b4-vhrm-12-477] Although the exact pathophysiology of preeclampsia is not completely understood, certain factors have been attributed to it, which include deficient trophoblastic invasion of the maternal vascular bed with subsequent reduction of placental blood flow.[@b5-vhrm-12-477],[@b6-vhrm-12-477] Placental under perfusion initiates widespread systemic, maternal endothelial dysfunction, and increased vascular permeability.[@b7-vhrm-12-477] Coagulation system is activated by the contact of platelets with the injured endothelium leading to increase in consumption as well as bone marrow production of platelets.[@b8-vhrm-12-477] Various indices are used to measure platelet functions, for example, the platelet count (PC), mean platelet volume (MPV), the PC to MPV ratio, and platelet distribution width (PDW); PDW measures platelet size distribution.[@b9-vhrm-12-477] The utility of different platelets indices as predictors of preeclampsia has been studied previously;[@b10-vhrm-12-477]--[@b21-vhrm-12-477] however, reports in this regard are controversial. The current study was conducted to evaluate platelets indices in women with preeclampsia.

Methods
=======

A retrospective case--control study was conducted at Maternity and Children's Hospital, Buraidah, Kingdom of Saudi Arabia (KSA) during the period of February--July 2016. Maternity and Children's Hospital is a tertiary care center for the Qassim region. Cases were women with preeclampsia, which was defined as "occurrence of hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg) in the second half of pregnancy (after 20 weeks of gestation) and proteinuria (presence of 300 mg or more of protein in 24 h urine sample or ≥2+ on dipstick)".[@b22-vhrm-12-477] Pre-eclampsia cases were considered mild or severe according to the diastolic blood pressure of \<110 or ≥110 mmHg, respectively.[@b23-vhrm-12-477] Healthy pregnant women attended for antenatal care were taken as controls. Women with thyroid disease, hypertension, renal disease, diabetes mellitus, and liver diseases were excluded from the study groups.

The medical records of both cases and controls were reviewed for obstetrics history (age, parity, and gestational age). Data were collected using predesigned questionnaire. Maternal weight and height were recorded, and body mass index (BMI) was calculated as kg/m^2^. Data of maternal hemogram taken at presentation were recorded. The hemogram included hemoglobin level, white blood cell (WBC) count, and platelet indices, namely PC, MPV, PDW, and PC to MPV ratio. The hemogram was performed using an automated hematology analyzer (Sysmex XN-9000; Sysmex Corporation, Hyogo, Japan).

A total sample size of 60 participants in each arm of the study groups was recorded to investigate the mean difference of the PC and MPV that would provide 80% power to detect a 5% difference at *a*=0.05, with an assumption that complete data might not be available for 10% of participants.

Ethics
------

This study was approved by Regional Research Ethical Committee, Ministry of Health, Qassim, KSA who deemed written consent was not required due to the retrospective nature of the study.

Statistics
----------

SPSS for Windows (version 20.0) was used for the data analyses. Continuous variables were checked for normality and their differences were compared between the cases and the controls using Student's *t*-test and Mann--Whitney *U*-test, when the data were normally and abnormally distributed, respectively. Binary regression was conducted, where pre-eclampsia was the dependent variable and medical, obstetrics, and platelets indices were the independent variable. Diagnostic screening tests were used to determine the diagnostic cutoffs of various parameters (based on test sensitivity and specificity) using receiver operating characteristic (ROC) curve. *P*\<0.05 was considered statistically significant.

Results
=======

While there was no significant difference in the basic characteristics (age, parity, and BMI) between the two study groups (60 women in each arm), gestational age was significantly lower in women with preeclampsia ([Table 1](#t1-vhrm-12-477){ref-type="table"}). Sixteen and 44 of the cases were suffering from severe and mild preeclampsia, respectively. There was no case with HELLP syndrome.

There was no significant difference in WBC, hematocrit (HCT), red cell distribution width (RDW), PDW, and MPV between the two groups. Both PC and PC to MPV ratio values were significantly lower in the cases compared with the controls ([Table 2](#t2-vhrm-12-477){ref-type="table"}).

WBC, HCT, RDW, PC, PDW, MPV, and PC to MPV ratio were not significantly different when mild and severe preeclampsia women were compared ([Table 3](#t3-vhrm-12-477){ref-type="table"}).

ROC curves were used to derive cutoffs for PC and the PC/MPV ratio. The PC cutoff was 248.0×10^3^/µL for diagnosis of preeclampsia (*P*=0.19). The area under the ROC curve was 62.4% (standard error =5.1%), which suggest poor predictability.

Based on binary regression analysis, women with PC \<248.010×10^3^/µL were at higher risk to have preeclampsia (odds ratio =2.2, 95% confidence interval =1.08--4.6, *P*=0.03). The PC/MPV cutoff was 31.2 for diagnosis of preeclampsia (*P*=0.035). The area under the ROC curve was 62.2%, and the standard error was 5.2% ([Figure 1](#f1-vhrm-12-477){ref-type="fig"}).

Discussion
==========

The current study demonstrated significantly lower PC and PC to MPV ratio in patients with preeclampsia compared with the normal controls but failed to show similar trend when MPV and PDW were evaluated in the same study groups. Recently, Doğan et al[@b14-vhrm-12-477] observed significantly lower PC and PC/MPV in preeclamptic women compared with the controls. The same study documented significantly higher MPV in preeclamptic women than the control group. Likewise, Freitas et al,[@b12-vhrm-12-477] reported lower PC in women with preeclampsia.

There was no significant difference in PDW in the current study. This goes with the previous findings, where Doğan et al[@b14-vhrm-12-477] found no significant difference in PDW among women with severe preeclampsia, mild preeclampsia, and healthy controls. Nonetheless, a significantly higher level of PDW has recently been observed among women with preeclampsia.[@b12-vhrm-12-477],[@b17-vhrm-12-477],[@b24-vhrm-12-477]

Although, the current study showed no difference in the MPV between the cases and the controls, the utility of MPV in predicting preeclampsia has been shown in several studies.[@b12-vhrm-12-477],[@b14-vhrm-12-477]--[@b16-vhrm-12-477],[@b18-vhrm-12-477]--[@b20-vhrm-12-477] It is worth to mention that Yavuzcan et al[@b21-vhrm-12-477] observed no significant difference in the MPV between women with severe preeclampsia, healthy pregnant women, and healthy non-pregnant women. It is noteworthy that some researchers failed to confirm PC and MPV as predictors of preeclampsia,[@b25-vhrm-12-477],[@b26-vhrm-12-477] probably because of the differences in the methods and/or equipment used to obtain hemogram.

Contact of platelets with the injured endothelium activates the coagulation system, which can increase both consumption and bone marrow production of platelets. Enhanced thrombopoiesis produces younger platelets, which are larger (increased MPV) than older platelets, and they are metabolically and enzymatically more active.[@b8-vhrm-12-477]

Aside from platelet parameters, there are several biomarkers of preeclampsia including soluble endoglin (sEng) or soluble fms-like tyrosine kinase-1 (sFlt-1).[@b27-vhrm-12-477] One limitation of this study is the lack of a comparative analysis between platelet parameters and sEng/sFlt-1. However, platelet parameters are simple laboratory markers and easy to check during antenatal care.

Conclusion
==========

The current study suggests that PC and the PC/MPV ratio are useful in risk evaluation of preeclampsia. Large scale prospective studies are needed from early pregnancy to reach a definitive conclusion.
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###### 

Characteristics of the cases and controls

  Variable                   Cases (n=60)   Controls (n=60)   *P*-value
  -------------------------- -------------- ----------------- -----------
  **Mean (SD)**                                               
  Age, years                 30.6 (6.0)     30.01(6.2)        0.504
  Parity                     2.3(1.8)       2..6(1.4)         0.521
  Gestational age, weeks     33.8(4.3)      32.9(4.0)         0.001
  Body mass index, kg/m^2^   31.0 (6.3)     29.7(6.1)         0.833

**Abbreviation:** SD, standard deviation.

###### 

Median (interquartile range) of hematological values in preeclamptic and control women

  -------------------------------------------------------------------------------------------------
  Variable                               Cases\                  Controls\              *P*-value
                                         (n=60)                  (n=60)                 
  -------------------------------------- ----------------------- ---------------------- -----------
  White blood cells, × 10^3^/µL          8.1 (6.7--9.9)          7.9 (5.8--9.9)         0.319

  Hematocrit, %                          35.4 (33.32--37.32)     34.3 (32.7--36.3)      0.3471

  Red cell distribution width, %         14.5 (13.4--17.2)       14.1 (13.4--15.0)      0.172

  Platelets count, × 10^3^/µL            236.5 (176.0--278.25)   259.0 (215.7--322.7)   0.019

  Mean platelet volume, fL               10.0 (9.3--10.8)        10.1 (9.4--10.8)       0.799

  Platelet distribution width, %         12.7 (11.4--15.8)       13.2 (11.4--14.9)      0.877

  Platelets count/mean platelet volume   22.2 (16.8--29.7)       26.1 (20.5--32.0)      0.035
  -------------------------------------------------------------------------------------------------

###### 

Median (interquartile range) of hematological values in the women with mild and severe preeclampsia

  -----------------------------------------------------------------------------------------------
  Variable                              Mild preeclampsia\     Severe preeclampsia\   *P*-value
                                        (n=16)                 (n=44)                 
  ------------------------------------- ---------------------- ---------------------- -----------
  White blood cells, × 10^3^/µL         8.2 (6.0--9.5)         8.1 (6.7--10.2)        0.519

  Hematocrit, %                         35.7 (33.7--37.1)      35.1 (33.0--37.3)      0.564

  Red cell distribution width, %        13.6 (12.8--15.8)      14.9 (13.7--17.4)      0.069

  Platelet count, ×10^3^/µL             249.0 (185.2--277.7)   219.0 (164.7--286.5)   0.300

  Mean platelet volume, fL              10.1 (9.3--10.6)       9.9 (9.3--11.4)        0.575

  Platelet distribution width, %        12.5 (11.4--14.1)      12.8 (11.4--16.0)      0.688

  Platelet count/mean platelet volume   24.2 (18.7--29.0)      20.6 (15.4--30.1)      0.380
  -----------------------------------------------------------------------------------------------
